This website is intended exclusively for healthcare professionals residing and/or working in the KSA.

IL4/IL13 are the central cytokines for type 2 inflammation in CRSwNP

Dupixent has rapid and sustained efficacy in CRSwNP with more than 50% reduction in mean nasal congestion.

New to Campus Sanofi? Register to access all our Content

YOU WILL NOW BE LEAVING THE SITE

By clicking on this link, you will be leaving Campus Sanofi website and going to another, entirely independent website.
Please note: Sanofi provides these links as a service to its website visitors and users; however, Sanofi takes no responsibility for the information on any website but their own.

Continue

This website is intended exclusively for healthcare professionals residing and/or working in the KSA.

Please choose if you are a healthcare professional and wish to continue on this site or if you are a member of the public to be redirected to the Sanofi website.